A digital tablet-based educational platform aimed at improving oral hygiene among people living with HIV to reduce inflammation and cardiovascular risks. The program integrates with HIV treatment clinics and includes provider discussions and dental referrals.
This innovative solution introduces a digital tablet-based educational program designed to enhance oral health care among people living with HIV (PLHIV). By improving oral hygiene practices, treatment for oral diseases, and ensuring routine dental visits, the program aims to reduce systemic inflammation and lower the risk of cardiovascular diseases (CVDs), which PLHIV are particularly susceptible to due to chronic inflammation not fully addressed by HIV medications.
Key features:
Target outcomes:
The current development stage of this solution is at Technology Readiness Level 3 (TRL 3). This indicates that the concept has been developed and is ready for further exploration through a multi-site randomized controlled trial involving HIV treatment centers in the US and Mexico. The trial will compare the efficacy of the education intervention against standard care over a 15-month period to evaluate changes in oral hygiene practices and associated health outcomes.
The University of Washington is a large public research university with campuses in Seattle, Bothell, and Tacoma, known for a broad portfolio from fundamental discovery to applied innovation. Industry partners engage through a South Lake Union research campus adjacent to a major life sciences district and through collaboration programs that place faculty and students alongside corporate R&D. The university’s integration with a major academic health system enables clinical translation and large-scale trials. Research is supported by competitive federal funding from NIH, NSF, DOE, and DoD. A dedicated technology transfer office manages IP, licensing, and startup incubation with prototyping resources.